Description
A look at key trends in in vitro diagnostics in the month of April 2017.
Sale!
What’s Trending in IVD – April 2017
$200.00 – $400.00
Table of Contents
- INTRODUCTION
- FIRST DIRECT-TO-CONSUMER TESTS FOR GENETIC RISK AUTHORIZED BY THE FDA
- ABBOTT AND ALERE FINALLY AGREE TO COMPLETE THE ACQUISITION
- NON-INVASIVE CANCER SCREENING – ATTRACTIVENESS OF THIS LARGE MARKET CONTINUES
- GUIDANCE ON VALIDATION OF NEXT GENERATION SEQUENCING-BASED ONCOLOGY PANELS
Related products
